Akèy › Dematomiyozit › Ohio
Etid klinik pou Dematomiyozit nan Ohio
5 etid pou Dematomiyozit ap chèche patisipan nan sit nan Ohio.
Vil nan Ohio
Tèks ofisyèl etid la (Anglè)
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Cleveland
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 24, 2026 · NCT06455449Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- Cleveland Clinic, Cleveland
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT05895786Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
- Cincinnati Children's Hospital Medical Center, Cincinnati
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT07089121Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
- Cleveland Clinic, Cleveland
Ap rekriteFaz 2
Laj 18 a 89 · Tout sèks · Mizajou Oct 8, 2025 · NCT06857240Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.